Patients with Cancer Can Teach Others About Resilience in the Face of the COVID-19 Pandemic

Video

As millions of people face a “new normal” during the COVID-19 pandemic, patients with cancer can teach others about the resilience needed to face the unknown.

Those who have experienced cancer can teach others about resilience and fearlessness in the face of the COVID-19 pandemic, says Martha Raymond.

The social isolation and fear of infection that many individuals are currently living with are already familiar to patients who have gone through cancer treatment, said the founder of the Raymond Foundation. Being familiar with the disruption and anxiety that comes with cancer gives patients a strength that others can learn from.

“I think there’s a lot that all of us can learn from cancer patients as we all go through this unprecedented pandemic.”

Transcription:

It really is a challenging time for the patient community, for sure. Things have resounded with us through our patient navigators and support groups, patients have an increased level of anxiety. Many are worried if they will be able to get their treatments as planned as many treatments have had to be postponed. Many patients are not able to get their scheduled scans, for example, PET scans or MRIs or CAT scans, to really determine if treatment is working, so that is very anxiety-producing.

And then, of course, so many clinical trials have stopped. So, patients who are looking for possible clinical trial enrollment as a line of therapy, in so many cases, a crucial need where time is of the essence for these individuals. It really is a stressful time.

One thing I would say, and it’s really remarkable for the cancer patient community, is even in times of this increased anxiety and stress due to COVID-19, cancer patients are so resilient. I think they show that every day. So many have said to me that they’ve lived this “new normal”. They’ve been in isolation; they’ve been worried about being immunocompromised. They’ve distanced themselves for so long anyway because they were worried that they might catch the flu or catch something.

So, while I think that while patients are struggling, it really speaks to their resilience and their courage to be able to say okay, we’ve got this. We understand what we have to do and we’re going to do everything we can to stay healthy. If we have to postpone a treatment or if we have to postpone a scan, then that’s what we have to do.

With all the scariness and the anxiety, I think it’s another opportunity for all of us to say, boy, these cancer patients, they have that strength and courage, and really are fearless when it comes to tackling a new obstacle in their way. I think there’s a lot that all of us can learn from cancer patients as we all go through this unprecedented pandemic.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.